Printer Friendly

TRSG Corp. Announces Congressmen Requesting Anthrax Testing at CDC.

Business Editors


TRSG Corp. (OTC BB: TSGO) Thursday announced that members of the United States Congress have offered the company's hand-held scanner for biological agents to the Center for Disease Control (CDC) for testing of the devices.

The company has retained the services of Advantage Associates of Washington, D.C., which enlisted the aid of lawmakers to get the testing done. Former U.S. Congressman Bill Sarpalius is president of Advantage, which is composed of 12 former members of Congress.

Sarpalius said he took the devices to members of Congress who readily agreed to help determine to what extent anthrax bacteria and spores could be detected. The V-Scan detects the presence of a range of biological agents.

"Capital Hill has been especially hard hit by the anthrax terrorism, but before we provide every House and Senate Office with a complimentary virus scanner, we felt it prudent that the CDC provide a reliable judgment on its effectiveness," Sarpalius said. He said, that members of Congress agreed that testing using CDC methodology would provide a comfort level.

Part of the problem the distributor has faced is not having access to anthrax for testing. There has been ongoing research of the product to verify its effectiveness in identifying the presence of a wide variety of biological agents. The V-Scan utilizes UV-A waves or waves in the 320 to 380 nm range, commonly referred to as black light or wood's light.

The product is for detection purposes only and is not intended as a treatment or cure. "Showing that the devices can detect these biological agents will mean that there is an easy method of checking suspicious areas and mail. It will relieve the minds of a lot of people, who currently have no clue when some bio agent might be lurking unseen to the naked eye," Sarpalius added.

The U.S. Capital complex has had several buildings closed in recent weeks as anthrax has been detected. A lingering question about the safety of the mail has been a complication and cause of concern for lawmaker offices. Currently, there is no readily available device in Capitol offices that can provide an indication of the presence of bacteria.

Testing for the agent has meant shutting down much of the activities of Congress. Only repeated testing could determine any subsequent influx in an already-tested area.

Because the V-Scan is small and inexpensive it can be used in every area simply by exposing a darkened surface to the light. The device is priced below $50 per unit. Sarpalius said it could be the inexpensive and available answer for all Americans that are fearful of bio-terrorism.

A number of statements contained in this press release are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

These forward-looking statements involve a number of risks and uncertainties, including the timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing.

The actual results that TRSG may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

The company believes it will benefit from the current need of business and consumers to seek higher levels of protection from potential biological agent contamination from unknown parties and can effectively compete with companies such as Cepheid (Nasdaq:CPHD) and Bruker Daltonics (Nasdaq: BDAL).

Initial signs of inhaled anthrax are flu-like symptoms, dry hacking cough, low-grade fever and weakness. Treatment entails the use of antibiotics (the current being Cipro), which both helps kill the bacteria and helps keep the patient stable until their immune system can build up immunity and finish the job.

One of the key benefits at TRSG is our immune-building products such as Master Formula. Betty Kamen, Ph.D. said, "Master Formula optimizes the immune system in many ways especially by building up the beneficial bacteria in your system that may provide up to 40 percent of your immune function."

For further information regarding our products or company information please refer to our Web sites at or
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 15, 2001
Previous Article:Dreyfus New York Municipal Income Announces Annual Earnings Report for the Fiscal Year Ended September 30, 2001.
Next Article:Dreyfus Strategic Municipals, Inc. Announces Annual Earnings Report for the Fiscal Year Ended September 30, 2001.

Related Articles
Cures for the privileged? government officials receive anthrax treatment prior to post office employees. (Washington Report).
CDC develops bio-threat test kits. (Tech Talk).
Public health in the time of bioterrorism. (Bioterrorism-Related Anthrax).
Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention. (Bioterrorism-Related Antrax).
Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. (Bioterrorism-Related Anthrax).
Epidemiologic response to anthrax outbreaks: field investigations, 1950-2001. (Anthrax Perspectives).
Testing reveals no anthrax on board mail sample. (Announcements).
CDC collaboration yields new test for anthrax.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters